In the group of women who were more than 10 years beyond menopause, we found no difference in atherosclerosis progression between women who were randomized to receive estradiol and placebo. Our ELITE trial results indicate that earlier initiation of estradiol within 6 years of menopause has the potential for reducing the progression of atherosclerosis.
On behalf of our entire ARU team, we would like to take the opportunity and thank all the participants involved in ELITE. ELITE was a landmark trial that has provided important scientific information heretofore unanswered.
For more details of the ELITE trial please read HERE.